Literature DB >> 10794842

Formation of diffuse and fibrillar tangles in aging and early Alzheimer's disease.

N V Uboga1, J L Price.   

Abstract

The changes in tau that are associated with the early formation of tangles in aging and in preclinical and very mild Alzheimer's Disease (AD) were studied with two antibodies against AD-specific tau: PHF-1, which recognizes a phosphorylated epitope at Ser396 through 404, and MC-1, which recognizes a folded, conformational epitope that includes amino acids at both 7 through 9 and 312 through 342. Both antibodies demonstrated cells with diffuse or granular staining (diffuse tangles) and cells with fibrillar staining (fibrillar tangles). The fibrillar tangles corresponded to classical tangles and increase exponentially with age and severity of AD. The diffuse tangles seemed to represent an earlier form of tangles; their density peaked around preclinical AD, and then decreased in more severe stages of AD. MC-1 consistently stained more diffuse tangles than PHF-1, suggesting that the conformational change in tau precedes phosphorylation at the PHF-1 epitope during paired helical filament formation.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10794842     DOI: 10.1016/s0197-4580(00)00091-9

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  11 in total

1.  Truncation of tau at E391 promotes early pathologic changes in transgenic mice.

Authors:  Pamela J McMillan; Brian C Kraemer; Linda Robinson; James B Leverenz; Murray Raskind; Gerard Schellenberg
Journal:  J Neuropathol Exp Neurol       Date:  2011-11       Impact factor: 3.685

2.  Frontal cortex neuropathology in dementia pugilistica.

Authors:  Tommy Saing; Malcolm Dick; Peter T Nelson; Ronald C Kim; David H Cribbs; Elizabeth Head
Journal:  J Neurotrauma       Date:  2012-04-10       Impact factor: 5.269

Review 3.  Gene-environment interplay in neurogenesis and neurodegeneration.

Authors:  Tomás Palomo; Trevor Archer; Richard J Beninger; Richard M Kostrzewa
Journal:  Neurotox Res       Date:  2004       Impact factor: 3.911

Review 4.  Neuropathological alterations in Alzheimer disease.

Authors:  Alberto Serrano-Pozo; Matthew P Frosch; Eliezer Masliah; Bradley T Hyman
Journal:  Cold Spring Harb Perspect Med       Date:  2011-09       Impact factor: 6.915

5.  Hsc70 rapidly engages tau after microtubule destabilization.

Authors:  Umesh K Jinwal; John C O'Leary; Sergiy I Borysov; Jeffrey R Jones; Qingyou Li; John Koren; Jose F Abisambra; Grant D Vestal; Lisa Y Lawson; Amelia G Johnson; Laura J Blair; Ying Jin; Yoshinari Miyata; Jason E Gestwicki; Chad A Dickey
Journal:  J Biol Chem       Date:  2010-03-22       Impact factor: 5.157

6.  Caspase-cleavage of tau is an early event in Alzheimer disease tangle pathology.

Authors:  Robert A Rissman; Wayne W Poon; Mathew Blurton-Jones; Salvatore Oddo; Reidun Torp; Michael P Vitek; Frank M LaFerla; Troy T Rohn; Carl W Cotman
Journal:  J Clin Invest       Date:  2004-07       Impact factor: 14.808

7.  Global axonal transport rates are unaltered in htau mice in vivo.

Authors:  Aidong Yuan; Asok Kumar; Takahiro Sasaki; Karen Duff; Ralph A Nixon
Journal:  J Alzheimers Dis       Date:  2013       Impact factor: 4.472

8.  Transcriptional vulnerability of brain regions in Alzheimer's disease and dementia.

Authors:  Vahram Haroutunian; Pavel Katsel; James Schmeidler
Journal:  Neurobiol Aging       Date:  2007-09-12       Impact factor: 4.673

9.  Yeast as a model system to study tau biology.

Authors:  Ann De Vos; Jayamani Anandhakumar; Jeff Van den Brande; Mathias Verduyckt; Vanessa Franssens; Joris Winderickx; Erwin Swinnen
Journal:  Int J Alzheimers Dis       Date:  2011-04-06

10.  Is there a neuropathology difference between mild cognitive impairment and dementia?

Authors:  Vahram Haroutunian; Lisa B Hoffman; Michal Schnaider Beeri
Journal:  Dialogues Clin Neurosci       Date:  2009       Impact factor: 5.986

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.